首页> 外国专利> Adefovir dipivoxil having a new crystal form, preparation method thereof, and compositon for preventing or treating chronic hepatitis B containing the same as an active ingredient

Adefovir dipivoxil having a new crystal form, preparation method thereof, and compositon for preventing or treating chronic hepatitis B containing the same as an active ingredient

机译:具有新晶体形式的阿德福韦酯,其制备方法和用于预防或治疗含有其作为有效成分的慢性乙型肝炎的组合物

摘要

The present invention relates to a new crystal form , their preparation and their use of adefovir Diffie acid , more particularly it is Cu in an X-ray diffraction pattern of the target radiation , the main characteristic peak indicated by the 2 3.3 0.1 and 6.6 Diffie of adefovir acid comprising a characteristic peak appearing at 0.1 new crystal form , its preparation method and containing the same as an active ingredient relates to a composition for the prevention or treatment of chronic hepatitis B infection . High and new crystal forms of adefovir Diffie acid according to the invention is stable , and the production method used in the reproducibility and hyeonjangseong , high yield and at least 90% , 99% can be produced in a new crystalline form of high purity adefovir Diffie acid , chronic can be useful in the prevention or treatment of hepatitis B . ;
机译:阿德福韦迪菲酸的新晶体形式及其制备和应用本发明涉及阿德福韦迪菲酸的一种新的晶型,制备及其应用,特别是目标辐射的X射线衍射图中的铜,主要特征峰由2 3.3 0.1和6.6迪菲表示具有出现在0.1个新晶形上的特征峰的阿德福韦酸的制备,制备方法和含有其作为有效成分的方法,涉及预防或治疗慢性乙型肝炎的组合物。本发明的阿德福韦酯Diffie酸的高新晶型是稳定的,并且以高纯度的阿德福韦酯Diffie的新晶型可以生产可再现性和生产性,高收率和至少90%,99%的生产方法慢性酸对预防或治疗乙型肝炎有用。 ;

著录项

  • 公开/公告号KR101258678B1

    专利类型

  • 公开/公告日2013-04-26

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20120021365

  • 申请日2012-02-29

  • 分类号C07D473/34;A61K31/675;A61K31/52;A61P31/12;

  • 国家 KR

  • 入库时间 2022-08-21 16:25:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号